BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...

Cellular Origins is a UK‑based company enabling scalable, factory‑led automation for cell and gene therapy manufacturing, and ...

Dr. Eva-Maria Hempe, NVIDIA, looks back at 2025 and ahead to 2026, noting that AI accelerates pharma overall, particularly in ...

AI has the potential to transform pharmaceutical supply chains by enhancing visibility and predicting disruptions. Traditional supply chains often suffer from a lack of transparency, making it ...

In the complex world of pharmaceutical manufacturing, pharma tech transfers – the process of moving manufacturing operations between facilities or phases – can present significant challenges. A recent ...

It’s truly a pleasure to interview Andrea Biffi, formerly a CEO in the MedTech world and today an entrepreneur, investor, and ...

Turbiscan technology accelerates lipid nanoparticle stability testing and supports robust pharmaceutical formulation ...

Ember LifeSciences is moving quickly to turn fresh capital into cold-chain scale. The healthcare logistics technology company ...

Goldman Sachs Group Inc. expects M&A activity in Italy to continue to expand in 2026, driven by banks, technology, telecom ...

Andrew Anderson shares insights on the factors that may shape the next major advance in pharmaceutical informatics strategy.

As the world prepares for long-term human missions to the Moon and Mars, researchers from Sunway University and Monash ...

Jessica Lin and Zhenqi (Pete) Shi from Genentech describe a novel machine learning approach to predicting retention times for ...